Results 131 to 140 of about 1,301,949 (212)

Once-weekly insulin icodec versus once-daily insulin degludec for type 2 diabetes in China: A cost-utility and budget impact analysis. [PDF]

Diabetes Obes Metab
Tong X, Zhang Y, Zhang L, Zhang L.
europepmc   +1 more source

An Enhanced Retention Strategy to Prevent the Vertical Transmission of HIV in Uganda: A Budget Impact Analysis. [PDF]

Pharmacoecon Open
Nuwamanya E, Johnson BC, Okoboi S, Galiwango R, Namuddu D, Ayabo T, Babigumira JB, Lamorde M.   +7 more
europepmc   +1 more source

Cost-utility and budget impact analysis of biosimilar trastuzumab for early-stage HER2-positive breast cancer in Thailand: an updated evaluation supporting expanded access. [PDF]

BMC Health Serv Res
Lochid-Amnuay S, Kongsakon R.
europepmc   +1 more source

Correction: Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States. [PDF]

Infect Dis Ther
Wilson M, Golan Y, Nguyen D, Yazdani M, Amin AN.   +4 more
europepmc   +1 more source

Beyond the COVID-19 Pandemic: Budget Impact Analysis of Remote Healthcare Delivery for Hypertension and Diabetes Mellitus Management in Thailand. [PDF]

Clinicoecon Outcomes Res
Chongpornchai J, Phodha T, Wongphan T, Soonklang K, Coyte PC.   +4 more
europepmc   +1 more source

Economic evaluation of cyclin-dependent kinases 4 and 6 inhibitors in advanced hormonal receptor-positive and human epidermal growth factor receptor 2 negative breast cancer: a nationwide budget impact analysis. [PDF]

J Pharm Policy Pract
Elazzazy S, Hisham Al-Ziftawi N, Shafei L, Mohamed Ibrahim MI, Bojassoum S, Hamad A.   +5 more
europepmc   +1 more source

Economic Evaluation and Budget Impact Analysis of Indocyanine Green Test for Preoperative Liver Function in Patients with Major Hepatectomy in Thailand. [PDF]

Adv Ther
Permsuwan U, Sriuttha P, Tovikkai C, Chotirosniramit A, Thepbunchonchai A, Junrungsee S, Lapisatepun W, Chaiyabutr K, Srisuk T, Dilokthornsakul P.   +9 more
europepmc   +1 more source

Budget impact analysis of revumenib for the treatment of relapsed or refractory acute leukemias with a KMT2A translocation in the United States. [PDF]

J Manag Care Spec Pharm
Abraham I, Martin P, Vaghela S, Klein T, Chow E, Rush M, Morlock R, Huang H.   +7 more
europepmc   +1 more source

Nationwide Hypothermic Machine Perfusion for ECD and DCD Kidney Transplantation in Belgium: One-Year Outcomes and Impact on Transplant Rates and Budget Impact Analysis. [PDF]

Transpl Int
Darius T, Jochmans I, Foguenne M, Hoste E, Randon C, Bracke B, Roeyen G, Gilbo N, Weekers L, Jacobs-Tulleneers-Thevissen D, Wissing KM, Bogaerts T, Mikhalski D, De Wilde JP, Daems J, Pirenne J.   +15 more
europepmc   +1 more source

PMC30 GUIDELINES FOR BUDGET IMPACT ANALYSIS IN CANADA

Value in Health, 2007
Marshall, D, Douglas, PR, Drummond, M, MacLeod, S   +3 more
openaire   +1 more source